Desq Long
Sign in

Company

UNITED THERAPEUTICS Corp

UTHR · CIK 0001082554

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$161,639.21

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $577.2829 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$92,574.82

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $578.5926 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$92,750.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $579.69 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$209,171.74

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $581.0326 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$232,732.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $581.832 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$443,147.87

UNITED THERAPEUTICS Corp (UTHR)

Sale of 760 shares at $583.0893 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$701,056.56

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,200 shares at $584.2138 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$1,027,683.55

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,756 shares at $585.2412 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$750,471.81

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,280 shares at $586.3061 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$550,244.07

UNITED THERAPEUTICS Corp (UTHR)

Sale of 937 shares at $587.2402 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$41,659.78

UNITED THERAPEUTICS Corp (UTHR)

Sale of 74 shares at $562.97 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$460,551.36

UNITED THERAPEUTICS Corp (UTHR)

Sale of 783 shares at $588.1882 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$141,480.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $589.50 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$94,463.52

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $590.397 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$62,037.34

UNITED THERAPEUTICS Corp (UTHR)

Sale of 110 shares at $563.9758 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$90,414.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $565.0875 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$91,213.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $570.0825 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$91,482.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $571.765 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$22,935.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $573.39 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$74,791.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 130 shares at $575.3178 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$109,592.34

UNITED THERAPEUTICS Corp (UTHR)

Sale of 190 shares at $576.8018 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001106578-26-000170 · filed 2026-10-23 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$112,288.58

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $561.4429 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$540,038.69

UNITED THERAPEUTICS Corp (UTHR)

Sale of 960 shares at $562.5403 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$705,971.78

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,253 shares at $563.4252 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$433,636.53

UNITED THERAPEUTICS Corp (UTHR)

Sale of 768 shares at $564.6309 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$271,370.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 480 shares at $565.355 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$45,314.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $566.43 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$25,416.11

UNITED THERAPEUTICS Corp (UTHR)

Sale of 46 shares at $552.5241 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$107,433.79

UNITED THERAPEUTICS Corp (UTHR)

Sale of 194 shares at $553.7824 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$305,357.03

UNITED THERAPEUTICS Corp (UTHR)

Sale of 550 shares at $555.1946 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$315,486.11

UNITED THERAPEUTICS Corp (UTHR)

Sale of 567 shares at $556.4129 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$948,431.67

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,702 shares at $557.2454 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$634,808.02

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,137 shares at $558.3184 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$415,521.41

UNITED THERAPEUTICS Corp (UTHR)

Sale of 743 shares at $559.2482 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$459,606.23

UNITED THERAPEUTICS Corp (UTHR)

Sale of 820 shares at $560.4954 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 22, 2026

Source: SEC Form 4 · 0001106578-26-000169 · filed 2026-10-22 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$88,814.46

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $555.0904 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$244,667.63

UNITED THERAPEUTICS Corp (UTHR)

Sale of 440 shares at $556.0628 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$178,279.90

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $557.1247 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$290,536.95

UNITED THERAPEUTICS Corp (UTHR)

Sale of 520 shares at $558.7249 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$156,716.81

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $559.7029 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$176,611.77

UNITED THERAPEUTICS Corp (UTHR)

Sale of 315 shares at $560.6723 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$202,263.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $561.8436 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$261,130.11

UNITED THERAPEUTICS Corp (UTHR)

Sale of 464 shares at $562.7804 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$124,547.78

UNITED THERAPEUTICS Corp (UTHR)

Sale of 221 shares at $563.5646 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$63,980.61

UNITED THERAPEUTICS Corp (UTHR)

Sale of 117 shares at $546.8428 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$314,976.72

UNITED THERAPEUTICS Corp (UTHR)

Sale of 575 shares at $547.7856 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$520,400.14

UNITED THERAPEUTICS Corp (UTHR)

Sale of 948 shares at $548.9453 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$322,311.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 586 shares at $550.0193 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$624,870.06

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,134 shares at $551.0318 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$860,883.04

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,560 shares at $551.8481 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$132,753.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $553.14 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$697,996.03

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,260 shares at $553.9651 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 20, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001106578-26-000168 · filed 2026-10-21 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$674,228.30

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,240 shares at $543.7325 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$566,689.66

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,040 shares at $544.8939 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$581,384.46

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,065 shares at $545.9009 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$227,553.12

UNITED THERAPEUTICS Corp (UTHR)

Sale of 416 shares at $547.0027 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$306,322.11

UNITED THERAPEUTICS Corp (UTHR)

Sale of 559 shares at $547.9823 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$197,644.36

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $549.0121 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$65,958.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $549.6567 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$44,142.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $551.775 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$22,111.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $552.78 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$66,479.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $553.9967 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$85,559.97

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $534.7498 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$44,550.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $556.875 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$193,087.98

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $536.3555 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$128,906.81

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $537.1117 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$86,166.53

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $538.5408 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$475,012.12

UNITED THERAPEUTICS Corp (UTHR)

Sale of 880 shares at $539.7865 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$973,132.56

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,800 shares at $540.6292 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$281,515.83

UNITED THERAPEUTICS Corp (UTHR)

Sale of 520 shares at $541.3766 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$141,130.37

UNITED THERAPEUTICS Corp (UTHR)

Sale of 260 shares at $542.8091 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$215,958.91

UNITED THERAPEUTICS Corp (UTHR)

Sale of 401 shares at $538.5509 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$128,964.45

UNITED THERAPEUTICS Corp (UTHR)

Sale of 239 shares at $539.6002 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$91,533.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 169 shares at $541.6201 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$212,185.34

UNITED THERAPEUTICS Corp (UTHR)

Sale of 391 shares at $542.6735 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$21,754.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $543.85 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$127,314.10

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $530.4754 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$544,295.63

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,024 shares at $531.5387 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$1,266,196.54

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,378 shares at $532.4628 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$969,578.67

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,818 shares at $533.3216 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$342,022.59

UNITED THERAPEUTICS Corp (UTHR)

Sale of 640 shares at $534.4103 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$286,581.58

UNITED THERAPEUTICS Corp (UTHR)

Sale of 535 shares at $535.6665 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$464,208.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 865 shares at $536.657 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$408,680.96

UNITED THERAPEUTICS Corp (UTHR)

Sale of 760 shares at $537.7381 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$1,119,183.04

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,039 shares at $548.8882 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$554,703.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,009 shares at $549.756 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$110,143.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $550.716 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$66,180.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $551.50 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$151,873.87

UNITED THERAPEUTICS Corp (UTHR)

Sale of 281 shares at $540.4764 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$629,864.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,163 shares at $541.5859 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$247,461.76

UNITED THERAPEUTICS Corp (UTHR)

Sale of 456 shares at $542.6793 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$201,598.77

UNITED THERAPEUTICS Corp (UTHR)

Sale of 371 shares at $543.3929 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$146,538.77

UNITED THERAPEUTICS Corp (UTHR)

Sale of 269 shares at $544.7538 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$450,346.63

UNITED THERAPEUTICS Corp (UTHR)

Sale of 825 shares at $545.8747 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$328,712.62

UNITED THERAPEUTICS Corp (UTHR)

Sale of 601 shares at $546.9428 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$1,186,592.85

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,166 shares at $547.8268 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001106578-26-000165 · filed 2026-10-16 · View filing →

SEC FORM 4
$1,212,049.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 8,300 shares at $146.03 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code M

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001231589-26-000022 · filed 2026-10-16 · View filing →

SEC FORM 4
$145,160.08

UNITED THERAPEUTICS Corp (UTHR)

Sale of 268 shares at $541.6421 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001231589-26-000022 · filed 2026-10-16 · View filing →

SEC FORM 4
$1,043,753.45

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,924 shares at $542.4914 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001231589-26-000022 · filed 2026-10-16 · View filing →

SEC FORM 4
$1,077,870.75

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,983 shares at $543.5556 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001231589-26-000022 · filed 2026-10-16 · View filing →

SEC FORM 4
$430,975.16

UNITED THERAPEUTICS Corp (UTHR)

Sale of 791 shares at $544.8485 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001231589-26-000022 · filed 2026-10-16 · View filing →

SEC FORM 4
$1,426,972.29

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,615 shares at $545.6873 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001231589-26-000022 · filed 2026-10-16 · View filing →

SEC FORM 4
$392,977.22

UNITED THERAPEUTICS Corp (UTHR)

Sale of 719 shares at $546.5608 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001231589-26-000022 · filed 2026-10-16 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$283,023.14

UNITED THERAPEUTICS Corp (UTHR)

Sale of 525 shares at $539.0917 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$1,081,544.26

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,002 shares at $540.2319 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$1,044,509.05

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,930 shares at $541.1964 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$478,644.37

UNITED THERAPEUTICS Corp (UTHR)

Sale of 883 shares at $542.0661 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$217,261.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $543.1545 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$261,288.91

UNITED THERAPEUTICS Corp (UTHR)

Sale of 480 shares at $544.3519 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$261,830.02

UNITED THERAPEUTICS Corp (UTHR)

Sale of 480 shares at $545.4792 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$21,840.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $546.00 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$21,042.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $526.07 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$84,814.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $530.0875 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$63,742.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $531.1867 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$21,299.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $532.48 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$128,311.99

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $534.6333 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$214,356.12

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $535.8903 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$340,038.61

UNITED THERAPEUTICS Corp (UTHR)

Sale of 633 shares at $537.1858 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$606,326.34

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,127 shares at $538.0003 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001106578-26-000164 · filed 2026-10-15 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001106578-26-000163 · filed 2026-10-14 · View filing →

SEC FORM 4
$88,094.86

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $550.5929 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001106578-26-000163 · filed 2026-10-14 · View filing →

SEC FORM 4
$44,119.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $551.49 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001106578-26-000163 · filed 2026-10-14 · View filing →

SEC FORM 4
$346,821.66

UNITED THERAPEUTICS Corp (UTHR)

Sale of 639 shares at $542.7569 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001106578-26-000163 · filed 2026-10-14 · View filing →

SEC FORM 4
$1,271,749.52

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,340 shares at $543.4827 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001106578-26-000163 · filed 2026-10-14 · View filing →

SEC FORM 4
$812,482.62

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,492 shares at $544.5594 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001106578-26-000163 · filed 2026-10-14 · View filing →

SEC FORM 4
$822,101.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,507 shares at $545.5221 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001106578-26-000163 · filed 2026-10-14 · View filing →

SEC FORM 4
$793,459.34

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,452 shares at $546.4596 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001106578-26-000163 · filed 2026-10-14 · View filing →

SEC FORM 4
$344,907.61

UNITED THERAPEUTICS Corp (UTHR)

Sale of 630 shares at $547.4724 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001106578-26-000163 · filed 2026-10-14 · View filing →

SEC FORM 4
$382,844.27

UNITED THERAPEUTICS Corp (UTHR)

Sale of 698 shares at $548.4875 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001106578-26-000163 · filed 2026-10-14 · View filing →

SEC FORM 4
$275,833.29

UNITED THERAPEUTICS Corp (UTHR)

Sale of 502 shares at $549.4687 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001106578-26-000163 · filed 2026-10-14 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000162 · filed 2026-10-13 · View filing →

SEC FORM 4
$234,599.08

UNITED THERAPEUTICS Corp (UTHR)

Sale of 428 shares at $548.1287 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000162 · filed 2026-10-13 · View filing →

SEC FORM 4
$729,639.07

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,329 shares at $549.0136 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000162 · filed 2026-10-13 · View filing →

SEC FORM 4
$1,410,824.90

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,565 shares at $550.0292 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000162 · filed 2026-10-13 · View filing →

SEC FORM 4
$1,448,297.37

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,628 shares at $551.1025 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000162 · filed 2026-10-13 · View filing →

SEC FORM 4
$1,024,919.71

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,857 shares at $551.9223 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000162 · filed 2026-10-13 · View filing →

SEC FORM 4
$308,534.61

UNITED THERAPEUTICS Corp (UTHR)

Sale of 558 shares at $552.9294 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000162 · filed 2026-10-13 · View filing →

SEC FORM 4
$74,851.67

UNITED THERAPEUTICS Corp (UTHR)

Sale of 135 shares at $554.4568 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000162 · filed 2026-10-13 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$21,660.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $541.51 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$130,371.19

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $543.2133 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$217,817.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $544.544 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$218,359.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $545.899 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$131,183.50

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $546.5979 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$481,154.62

UNITED THERAPEUTICS Corp (UTHR)

Sale of 878 shares at $548.0121 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$1,449,736.01

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,641 shares at $548.9345 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$812,796.39

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,478 shares at $549.9299 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$232,954.43

UNITED THERAPEUTICS Corp (UTHR)

Sale of 423 shares at $550.7197 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$63,830.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $531.92 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$170,816.22

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $533.8007 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$342,270.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 640 shares at $534.7975 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$214,436.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $536.09 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$193,336.63

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $537.0462 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$215,330.08

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $538.3252 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$107,845.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $539.228 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$173,036.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $540.74 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 9, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$491,539.35

UNITED THERAPEUTICS Corp (UTHR)

Sale of 920 shares at $534.2819 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$257,019.94

UNITED THERAPEUTICS Corp (UTHR)

Sale of 480 shares at $535.4582 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$442,164.50

UNITED THERAPEUTICS Corp (UTHR)

Sale of 824 shares at $536.6074 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$546,134.14

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,016 shares at $537.5336 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$325,853.24

UNITED THERAPEUTICS Corp (UTHR)

Sale of 605 shares at $538.6004 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$588,682.43

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,091 shares at $539.5806 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$229,175.05

UNITED THERAPEUTICS Corp (UTHR)

Sale of 424 shares at $540.5072 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$21,649.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $541.23 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$105,099.16

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $525.4958 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$403,951.13

UNITED THERAPEUTICS Corp (UTHR)

Sale of 767 shares at $526.6638 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$144,027.84

UNITED THERAPEUTICS Corp (UTHR)

Sale of 273 shares at $527.5745 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$105,725.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $528.626 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$105,496.71

UNITED THERAPEUTICS Corp (UTHR)

Sale of 199 shares at $530.1342 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$563,467.92

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,061 shares at $531.0725 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$319,244.22

UNITED THERAPEUTICS Corp (UTHR)

Sale of 600 shares at $532.0737 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$426,688.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 800 shares at $533.361 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 8, 2026 · Disclosed Oct 9, 2026

Source: SEC Form 4 · 0001106578-26-000160 · filed 2026-10-09 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$267,831.78

UNITED THERAPEUTICS Corp (UTHR)

Sale of 486 shares at $551.0942 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$243,009.76

UNITED THERAPEUTICS Corp (UTHR)

Sale of 440 shares at $552.2949 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$102,434.85

UNITED THERAPEUTICS Corp (UTHR)

Sale of 185 shares at $553.7019 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$268,938.61

UNITED THERAPEUTICS Corp (UTHR)

Sale of 485 shares at $554.5126 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$516,868.52

UNITED THERAPEUTICS Corp (UTHR)

Sale of 930 shares at $555.7726 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$222,593.92

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $556.4848 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$95,521.17

UNITED THERAPEUTICS Corp (UTHR)

Sale of 176 shares at $542.7339 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$404,556.84

UNITED THERAPEUTICS Corp (UTHR)

Sale of 744 shares at $543.7592 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$1,143,034.88

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,098 shares at $544.8212 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$269,104.30

UNITED THERAPEUTICS Corp (UTHR)

Sale of 493 shares at $545.8505 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$344,027.90

UNITED THERAPEUTICS Corp (UTHR)

Sale of 629 shares at $546.9442 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$212,144.50

UNITED THERAPEUTICS Corp (UTHR)

Sale of 387 shares at $548.177 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$644,129.61

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,173 shares at $549.1301 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$480,818.51

UNITED THERAPEUTICS Corp (UTHR)

Sale of 874 shares at $550.1356 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 7, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$71,497.58

UNITED THERAPEUTICS Corp (UTHR)

Sale of 133 shares at $537.5758 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$586,005.83

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,088 shares at $538.6083 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$866,718.37

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,606 shares at $539.6752 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$1,110,553.23

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,054 shares at $540.6783 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$205,790.86

UNITED THERAPEUTICS Corp (UTHR)

Sale of 380 shares at $541.5549 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$65,098.84

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $542.4903 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$303,548.48

UNITED THERAPEUTICS Corp (UTHR)

Sale of 558 shares at $543.9937 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$458,681.18

UNITED THERAPEUTICS Corp (UTHR)

Sale of 842 shares at $544.752 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$43,639.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $545.495 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$147,812.81

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $527.9029 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$190,339.09

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $528.7197 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$127,231.99

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $530.1333 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$170,220.29

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $531.9384 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$114,625.94

UNITED THERAPEUTICS Corp (UTHR)

Sale of 215 shares at $533.1439 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$89,228.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 167 shares at $534.3018 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$393,210.19

UNITED THERAPEUTICS Corp (UTHR)

Sale of 734 shares at $535.7087 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$173,209.23

UNITED THERAPEUTICS Corp (UTHR)

Sale of 323 shares at $536.2515 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001106578-26-000158 · filed 2026-10-07 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$686,186.93

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,260 shares at $544.5928 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$502,036.82

UNITED THERAPEUTICS Corp (UTHR)

Sale of 920 shares at $545.6922 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$196,787.59

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $546.6322 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$268,665.21

UNITED THERAPEUTICS Corp (UTHR)

Sale of 501 shares at $536.2579 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$486,373.15

UNITED THERAPEUTICS Corp (UTHR)

Sale of 905 shares at $537.4289 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$352,795.25

UNITED THERAPEUTICS Corp (UTHR)

Sale of 655 shares at $538.6187 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$502,278.88

UNITED THERAPEUTICS Corp (UTHR)

Sale of 931 shares at $539.5047 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$555,632.77

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,028 shares at $540.4988 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$671,120.21

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,239 shares at $541.6628 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$498,066.96

UNITED THERAPEUTICS Corp (UTHR)

Sale of 918 shares at $542.5566 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$425,593.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 783 shares at $543.5419 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001106578-26-000157 · filed 2026-10-06 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$238,027.12

UNITED THERAPEUTICS Corp (UTHR)

Sale of 432 shares at $550.9887 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$400,067.25

UNITED THERAPEUTICS Corp (UTHR)

Sale of 725 shares at $551.8169 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$88,457.01

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $552.8563 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$44,344.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $554.30 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$44,448.34

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $555.6043 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$133,783.56

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $557.4315 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$67,031.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $558.5967 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$67,279.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $560.66 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$22,494.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $562.35 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$45,110.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $563.88 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$379,442.98

UNITED THERAPEUTICS Corp (UTHR)

Sale of 700 shares at $542.0614 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$45,326.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $566.58 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$136,775.35

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $569.8973 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$68,483.63

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $570.6969 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$45,794.95

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $572.4369 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$22,969.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $574.225 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$221,492.35

UNITED THERAPEUTICS Corp (UTHR)

Sale of 408 shares at $542.8734 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$561,588.50

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,032 shares at $544.1749 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$697,471.49

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,280 shares at $544.8996 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$168,944.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 309 shares at $546.7466 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$641,699.33

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,171 shares at $547.9926 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$661,943.13

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,206 shares at $548.8749 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$416,040.46

UNITED THERAPEUTICS Corp (UTHR)

Sale of 757 shares at $549.5911 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 2, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001106578-26-000156 · filed 2026-10-05 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$160,614.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $573.6243 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$477,203.52

UNITED THERAPEUTICS Corp (UTHR)

Sale of 830 shares at $574.944 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$775,165.03

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,346 shares at $575.9027 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$446,524.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 774 shares at $576.9053 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$537,477.13

UNITED THERAPEUTICS Corp (UTHR)

Sale of 930 shares at $577.9324 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$185,286.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $579.02 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$501,291.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 864 shares at $580.1984 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$408,011.81

UNITED THERAPEUTICS Corp (UTHR)

Sale of 702 shares at $581.2134 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$302,765.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 520 shares at $582.2412 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$233,313.24

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $583.2831 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$67,206.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $560.05 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$210,478.39

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $584.6622 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$44,934.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $561.68 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$90,129.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $563.31 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$53,382.86

UNITED THERAPEUTICS Corp (UTHR)

Sale of 94 shares at $567.9028 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$174,313.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 306 shares at $569.6523 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$304,673.43

UNITED THERAPEUTICS Corp (UTHR)

Sale of 534 shares at $570.5495 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$182,887.62

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $571.5238 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$320,803.06

UNITED THERAPEUTICS Corp (UTHR)

Sale of 560 shares at $572.8626 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001106578-26-000155 · filed 2026-10-02 · View filing →

SEC FORM 4
$1,212,049.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 8,300 shares at $146.03 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code M

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001231589-26-000021 · filed 2026-10-01 · View filing →

SEC FORM 4
$470,961.09

UNITED THERAPEUTICS Corp (UTHR)

Sale of 823 shares at $572.2492 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001231589-26-000021 · filed 2026-10-01 · View filing →

SEC FORM 4
$91,704.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $573.15 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001231589-26-000021 · filed 2026-10-01 · View filing →

SEC FORM 4
$491,307.78

UNITED THERAPEUTICS Corp (UTHR)

Sale of 880 shares at $558.3043 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001231589-26-000021 · filed 2026-10-01 · View filing →

SEC FORM 4
$829,082.68

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,480 shares at $560.191 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001231589-26-000021 · filed 2026-10-01 · View filing →

SEC FORM 4
$438,258.99

UNITED THERAPEUTICS Corp (UTHR)

Sale of 780 shares at $561.8705 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001231589-26-000021 · filed 2026-10-01 · View filing →

SEC FORM 4
$833,373.79

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,480 shares at $563.0904 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001231589-26-000021 · filed 2026-10-01 · View filing →

SEC FORM 4
$226,562.48

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $566.4062 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001231589-26-000021 · filed 2026-10-01 · View filing →

SEC FORM 4
$408,788.28

UNITED THERAPEUTICS Corp (UTHR)

Sale of 720 shares at $567.7615 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001231589-26-000021 · filed 2026-10-01 · View filing →

SEC FORM 4
$420,600.37

UNITED THERAPEUTICS Corp (UTHR)

Sale of 739 shares at $569.148 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001231589-26-000021 · filed 2026-10-01 · View filing →

SEC FORM 4
$478,411.18

UNITED THERAPEUTICS Corp (UTHR)

Sale of 838 shares at $570.8964 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001231589-26-000021 · filed 2026-10-01 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$20,454.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $511.37 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$41,192.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $514.90 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$41,373.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $517.165 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$41,868.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $523.36 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$41,969.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $524.62 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$42,087.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $526.09 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$84,977.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $531.11 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$85,843.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $536.52 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$107,534.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $537.67 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$21,546.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $538.65 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$76,658.81

UNITED THERAPEUTICS Corp (UTHR)

Sale of 161 shares at $476.1417 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$259,573.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 480 shares at $540.7775 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$314,221.73

UNITED THERAPEUTICS Corp (UTHR)

Sale of 580 shares at $541.7616 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$325,947.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 600 shares at $543.245 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$457,000.32

UNITED THERAPEUTICS Corp (UTHR)

Sale of 840 shares at $544.048 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$501,518.68

UNITED THERAPEUTICS Corp (UTHR)

Sale of 920 shares at $545.129 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$196,643.59

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $546.2322 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$357,592.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 749 shares at $477.4259 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$311,003.94

UNITED THERAPEUTICS Corp (UTHR)

Sale of 650 shares at $478.4676 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$172,200.92

UNITED THERAPEUTICS Corp (UTHR)

Sale of 359 shares at $479.6683 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$288,957.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 601 shares at $480.7942 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$77,177.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $482.3575 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$39,023.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $487.79 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$19,812.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $495.32 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →

SEC FORM 4
$218,917.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $547.294 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000154 · filed 2026-10-01 · View filing →

SEC FORM 4
$153,510.81

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $548.2529 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000154 · filed 2026-10-01 · View filing →

SEC FORM 4
$131,855.45

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $549.3977 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000154 · filed 2026-10-01 · View filing →

SEC FORM 4
$220,187.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $550.4675 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000154 · filed 2026-10-01 · View filing →

SEC FORM 4
$88,239.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $551.495 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000154 · filed 2026-10-01 · View filing →

SEC FORM 4
$66,315.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $552.6267 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000154 · filed 2026-10-01 · View filing →

SEC FORM 4
$62,576.99

UNITED THERAPEUTICS Corp (UTHR)

Sale of 113 shares at $553.7787 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000154 · filed 2026-10-01 · View filing →

SEC FORM 4
$114,822.84

UNITED THERAPEUTICS Corp (UTHR)

Sale of 207 shares at $554.6997 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001106578-26-000154 · filed 2026-10-01 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$76,734.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $479.59 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$240,612.05

UNITED THERAPEUTICS Corp (UTHR)

Sale of 500 shares at $481.2241 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$57,873.67

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $482.2806 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$97,354.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $486.77 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$188,818.08

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $472.0452 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$212,362.72

UNITED THERAPEUTICS Corp (UTHR)

Sale of 449 shares at $472.9682 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$37,908.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $473.8553 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$262,263.48

UNITED THERAPEUTICS Corp (UTHR)

Sale of 552 shares at $475.115 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$664,160.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,395 shares at $476.1005 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$1,018,580.74

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,135 shares at $477.087 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$1,103,922.74

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,309 shares at $478.0956 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$574,889.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,200 shares at $479.0745 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 29, 2026 · Disclosed Sep 30, 2026

Source: SEC Form 4 · 0001106578-26-000152 · filed 2026-09-30 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$651,541.69

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,354 shares at $481.1977 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$334,103.96

UNITED THERAPEUTICS Corp (UTHR)

Sale of 693 shares at $482.1125 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$743,647.88

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,539 shares at $483.202 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$399,684.53

UNITED THERAPEUTICS Corp (UTHR)

Sale of 825 shares at $484.4661 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$638,372.54

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,315 shares at $485.4544 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$77,760.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $486.005 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$132,279.67

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $472.4274 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$283,965.72

UNITED THERAPEUTICS Corp (UTHR)

Sale of 600 shares at $473.2762 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$322,629.47

UNITED THERAPEUTICS Corp (UTHR)

Sale of 680 shares at $474.4551 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$38,022.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $475.28 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$76,268.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $476.675 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$95,489.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $477.448 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$287,913.32

UNITED THERAPEUTICS Corp (UTHR)

Sale of 601 shares at $479.0571 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$486,426.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,013 shares at $480.1843 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001106578-26-000151 · filed 2026-09-29 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 25, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001106578-26-000150 · filed 2026-09-28 · View filing →

SEC FORM 4
$302,697.79

UNITED THERAPEUTICS Corp (UTHR)

Sale of 632 shares at $478.9522 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 25, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001106578-26-000150 · filed 2026-09-28 · View filing →

SEC FORM 4
$18,822.26

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $470.5565 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 25, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001106578-26-000150 · filed 2026-09-28 · View filing →

SEC FORM 4
$94,367.56

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $471.8378 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 25, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001106578-26-000150 · filed 2026-09-28 · View filing →

SEC FORM 4
$378,308.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 800 shares at $472.886 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 25, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001106578-26-000150 · filed 2026-09-28 · View filing →

SEC FORM 4
$257,461.93

UNITED THERAPEUTICS Corp (UTHR)

Sale of 543 shares at $474.1472 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 25, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001106578-26-000150 · filed 2026-09-28 · View filing →

SEC FORM 4
$766,622.61

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,613 shares at $475.2775 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 25, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001106578-26-000150 · filed 2026-09-28 · View filing →

SEC FORM 4
$1,306,507.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,744 shares at $476.1324 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 25, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001106578-26-000150 · filed 2026-09-28 · View filing →

SEC FORM 4
$610,805.12

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,280 shares at $477.1915 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 25, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001106578-26-000150 · filed 2026-09-28 · View filing →

SEC FORM 4
$788,041.79

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,648 shares at $478.1807 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 25, 2026 · Disclosed Sep 28, 2026

Source: SEC Form 4 · 0001106578-26-000150 · filed 2026-09-28 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$708,336.58

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,480 shares at $478.6058 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$287,710.02

UNITED THERAPEUTICS Corp (UTHR)

Sale of 600 shares at $479.5167 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$19,213.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $480.33 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$300,630.53

UNITED THERAPEUTICS Corp (UTHR)

Sale of 640 shares at $469.7352 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$1,225,044.68

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,603 shares at $470.628 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$1,019,026.22

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,160 shares at $471.7714 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$274,183.86

UNITED THERAPEUTICS Corp (UTHR)

Sale of 580 shares at $472.7308 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$207,140.58

UNITED THERAPEUTICS Corp (UTHR)

Sale of 437 shares at $474.0059 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$152,113.50

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $475.3547 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$133,423.72

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $476.5133 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$171,929.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $477.5825 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001106578-26-000149 · filed 2026-09-25 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$380,907.67

UNITED THERAPEUTICS Corp (UTHR)

Sale of 766 shares at $497.2685 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$134,563.06

UNITED THERAPEUTICS Corp (UTHR)

Sale of 270 shares at $498.3817 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$44,900.94

UNITED THERAPEUTICS Corp (UTHR)

Sale of 90 shares at $498.8993 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$120,012.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $500.05 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$1,167,006.53

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,388 shares at $488.6962 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$1,058,350.89

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,162 shares at $489.524 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$706,286.16

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,440 shares at $490.4765 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$405,123.64

UNITED THERAPEUTICS Corp (UTHR)

Sale of 824 shares at $491.6549 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$236,421.41

UNITED THERAPEUTICS Corp (UTHR)

Sale of 480 shares at $492.5446 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$78,995.74

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $493.7234 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$76,751.58

UNITED THERAPEUTICS Corp (UTHR)

Sale of 155 shares at $495.1715 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$260,597.93

UNITED THERAPEUTICS Corp (UTHR)

Sale of 525 shares at $496.377 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001106578-26-000148 · filed 2026-09-24 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001106578-26-000147 · filed 2026-09-23 · View filing →

SEC FORM 4
$675,911.50

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,358 shares at $497.7257 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001106578-26-000147 · filed 2026-09-23 · View filing →

SEC FORM 4
$79,850.90

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $499.0681 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001106578-26-000147 · filed 2026-09-23 · View filing →

SEC FORM 4
$117,506.90

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $489.6121 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001106578-26-000147 · filed 2026-09-23 · View filing →

SEC FORM 4
$207,988.03

UNITED THERAPEUTICS Corp (UTHR)

Sale of 424 shares at $490.5378 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001106578-26-000147 · filed 2026-09-23 · View filing →

SEC FORM 4
$361,704.92

UNITED THERAPEUTICS Corp (UTHR)

Sale of 736 shares at $491.4469 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001106578-26-000147 · filed 2026-09-23 · View filing →

SEC FORM 4
$309,395.38

UNITED THERAPEUTICS Corp (UTHR)

Sale of 628 shares at $492.6678 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001106578-26-000147 · filed 2026-09-23 · View filing →

SEC FORM 4
$812,139.46

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,645 shares at $493.7018 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001106578-26-000147 · filed 2026-09-23 · View filing →

SEC FORM 4
$661,358.41

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,337 shares at $494.6585 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001106578-26-000147 · filed 2026-09-23 · View filing →

SEC FORM 4
$737,700.11

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,488 shares at $495.7662 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001106578-26-000147 · filed 2026-09-23 · View filing →

SEC FORM 4
$737,294.98

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,484 shares at $496.8295 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0001106578-26-000147 · filed 2026-09-23 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 21, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001106578-26-000146 · filed 2026-09-22 · View filing →

SEC FORM 4
$749,320.78

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,520 shares at $492.9742 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001106578-26-000146 · filed 2026-09-22 · View filing →

SEC FORM 4
$1,322,851.22

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,680 shares at $493.6012 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001106578-26-000146 · filed 2026-09-22 · View filing →

SEC FORM 4
$1,073,751.15

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,170 shares at $494.8162 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001106578-26-000146 · filed 2026-09-22 · View filing →

SEC FORM 4
$1,133,693.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,287 shares at $495.7122 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001106578-26-000146 · filed 2026-09-22 · View filing →

SEC FORM 4
$418,653.78

UNITED THERAPEUTICS Corp (UTHR)

Sale of 843 shares at $496.6237 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001106578-26-000146 · filed 2026-09-22 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001106578-26-000145 · filed 2026-09-21 · View filing →

SEC FORM 4
$122,240.51

UNITED THERAPEUTICS Corp (UTHR)

Sale of 248 shares at $492.9053 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001106578-26-000145 · filed 2026-09-21 · View filing →

SEC FORM 4
$1,094,209.39

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,216 shares at $493.7768 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001106578-26-000145 · filed 2026-09-21 · View filing →

SEC FORM 4
$2,111,871.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 4,269 shares at $494.6993 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001106578-26-000145 · filed 2026-09-21 · View filing →

SEC FORM 4
$1,154,894.32

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,330 shares at $495.6628 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001106578-26-000145 · filed 2026-09-21 · View filing →

SEC FORM 4
$137,569.14

UNITED THERAPEUTICS Corp (UTHR)

Sale of 277 shares at $496.6395 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001106578-26-000145 · filed 2026-09-21 · View filing →

SEC FORM 4
$79,720.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $498.25 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001106578-26-000145 · filed 2026-09-21 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001106578-26-000144 · filed 2026-09-18 · View filing →

SEC FORM 4
$80,256.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $501.6025 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001106578-26-000144 · filed 2026-09-18 · View filing →

SEC FORM 4
$295,436.08

UNITED THERAPEUTICS Corp (UTHR)

Sale of 599 shares at $493.2155 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001106578-26-000144 · filed 2026-09-18 · View filing →

SEC FORM 4
$865,095.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,750 shares at $494.3404 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001106578-26-000144 · filed 2026-09-18 · View filing →

SEC FORM 4
$943,183.22

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,905 shares at $495.1093 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001106578-26-000144 · filed 2026-09-18 · View filing →

SEC FORM 4
$1,082,720.84

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,182 shares at $496.2057 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001106578-26-000144 · filed 2026-09-18 · View filing →

SEC FORM 4
$970,978.28

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,953 shares at $497.1727 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001106578-26-000144 · filed 2026-09-18 · View filing →

SEC FORM 4
$75,165.88

UNITED THERAPEUTICS Corp (UTHR)

Sale of 151 shares at $497.7873 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001106578-26-000144 · filed 2026-09-18 · View filing →

SEC FORM 4
$165,701.10

UNITED THERAPEUTICS Corp (UTHR)

Sale of 332 shares at $499.0997 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001106578-26-000144 · filed 2026-09-18 · View filing →

SEC FORM 4
$234,042.96

UNITED THERAPEUTICS Corp (UTHR)

Sale of 468 shares at $500.0918 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001106578-26-000144 · filed 2026-09-18 · View filing →

SEC FORM 4
$1,212,049.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 8,300 shares at $146.03 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code M

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001231589-26-000020 · filed 2026-09-18 · View filing →

SEC FORM 4
$783,131.89

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,579 shares at $495.967 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001231589-26-000020 · filed 2026-09-18 · View filing →

SEC FORM 4
$1,426,662.27

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,873 shares at $496.5758 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001231589-26-000020 · filed 2026-09-18 · View filing →

SEC FORM 4
$696,560.76

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,400 shares at $497.5434 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001231589-26-000020 · filed 2026-09-18 · View filing →

SEC FORM 4
$420,435.29

UNITED THERAPEUTICS Corp (UTHR)

Sale of 843 shares at $498.737 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001231589-26-000020 · filed 2026-09-18 · View filing →

SEC FORM 4
$579,711.74

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,160 shares at $499.7515 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001231589-26-000020 · filed 2026-09-18 · View filing →

SEC FORM 4
$62,600.22

UNITED THERAPEUTICS Corp (UTHR)

Sale of 125 shares at $500.8018 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001231589-26-000020 · filed 2026-09-18 · View filing →

SEC FORM 4
$160,505.79

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $501.5806 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001231589-26-000020 · filed 2026-09-18 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001106578-26-000143 · filed 2026-09-17 · View filing →

SEC FORM 4
$1,036,777.04

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,080 shares at $498.4505 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001106578-26-000143 · filed 2026-09-17 · View filing →

SEC FORM 4
$608,966.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,220 shares at $499.1528 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001106578-26-000143 · filed 2026-09-17 · View filing →

SEC FORM 4
$246,095.69

UNITED THERAPEUTICS Corp (UTHR)

Sale of 492 shares at $500.1945 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001106578-26-000143 · filed 2026-09-17 · View filing →

SEC FORM 4
$355,076.58

UNITED THERAPEUTICS Corp (UTHR)

Sale of 708 shares at $501.5206 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001106578-26-000143 · filed 2026-09-17 · View filing →

SEC FORM 4
$1,085,271.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,160 shares at $502.4406 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001106578-26-000143 · filed 2026-09-17 · View filing →

SEC FORM 4
$774,428.99

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,538 shares at $503.5299 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001106578-26-000143 · filed 2026-09-17 · View filing →

SEC FORM 4
$595,931.78

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,182 shares at $504.1724 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001106578-26-000143 · filed 2026-09-17 · View filing →

SEC FORM 4
$60,624.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $505.20 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001106578-26-000143 · filed 2026-09-17 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001106578-26-000142 · filed 2026-09-16 · View filing →

SEC FORM 4
$389,823.88

UNITED THERAPEUTICS Corp (UTHR)

Sale of 780 shares at $499.7742 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001106578-26-000142 · filed 2026-09-16 · View filing →

SEC FORM 4
$1,858,019.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 3,711 shares at $500.6789 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001106578-26-000142 · filed 2026-09-16 · View filing →

SEC FORM 4
$1,348,969.92

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,689 shares at $501.6623 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001106578-26-000142 · filed 2026-09-16 · View filing →

SEC FORM 4
$414,620.33

UNITED THERAPEUTICS Corp (UTHR)

Sale of 825 shares at $502.5701 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001106578-26-000142 · filed 2026-09-16 · View filing →

SEC FORM 4
$425,714.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 845 shares at $503.8045 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001106578-26-000142 · filed 2026-09-16 · View filing →

SEC FORM 4
$327,970.96

UNITED THERAPEUTICS Corp (UTHR)

Sale of 650 shares at $504.5707 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001106578-26-000142 · filed 2026-09-16 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001106578-26-000141 · filed 2026-09-15 · View filing →

SEC FORM 4
$793,398.90

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,580 shares at $502.1512 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001106578-26-000141 · filed 2026-09-15 · View filing →

SEC FORM 4
$1,187,112.93

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,358 shares at $503.4406 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001106578-26-000141 · filed 2026-09-15 · View filing →

SEC FORM 4
$1,373,179.59

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,722 shares at $504.4745 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001106578-26-000141 · filed 2026-09-15 · View filing →

SEC FORM 4
$1,212,609.12

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,400 shares at $505.2538 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001106578-26-000141 · filed 2026-09-15 · View filing →

SEC FORM 4
$222,851.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 440 shares at $506.4805 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001106578-26-000141 · filed 2026-09-15 · View filing →

SEC FORM 4
$14,411.80

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 130 shares at $110.86 per share.

Reporting Person Mesa Nilda · Transaction Code M

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001756697-26-000004 · filed 2026-09-15 · View filing →

SEC FORM 4
$65,752.28

UNITED THERAPEUTICS Corp (UTHR)

Sale of 130 shares at $505.7868 per share.

Reporting Person Mesa Nilda · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001756697-26-000004 · filed 2026-09-15 · View filing →

SEC FORM 4
$49,585.55

UNITED THERAPEUTICS Corp (UTHR)

Sale of 98 shares at $505.975 per share.

Reporting Person Mesa Nilda · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001756697-26-000004 · filed 2026-09-15 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$41,407.36

UNITED THERAPEUTICS Corp (UTHR)

Sale of 82 shares at $504.9678 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$262,336.33

UNITED THERAPEUTICS Corp (UTHR)

Sale of 518 shares at $506.4408 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$162,337.63

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $507.3051 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$142,298.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $508.21 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$666,125.52

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,341 shares at $496.7379 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$1,064,700.27

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,138 shares at $497.9889 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$509,445.61

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,021 shares at $498.9673 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$101,921.44

UNITED THERAPEUTICS Corp (UTHR)

Sale of 204 shares at $499.6149 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$238,408.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 476 shares at $500.8584 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$783,323.11

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,560 shares at $502.1302 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$427,633.81

UNITED THERAPEUTICS Corp (UTHR)

Sale of 850 shares at $503.0986 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$357,834.89

UNITED THERAPEUTICS Corp (UTHR)

Sale of 710 shares at $503.9928 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001106578-26-000140 · filed 2026-09-14 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001106578-26-000139 · filed 2026-09-11 · View filing →

SEC FORM 4
$141,893.39

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $506.7621 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001106578-26-000139 · filed 2026-09-11 · View filing →

SEC FORM 4
$142,465.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $508.8043 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001106578-26-000139 · filed 2026-09-11 · View filing →

SEC FORM 4
$59,812.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $498.44 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001106578-26-000139 · filed 2026-09-11 · View filing →

SEC FORM 4
$893,547.64

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,788 shares at $499.747 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001106578-26-000139 · filed 2026-09-11 · View filing →

SEC FORM 4
$686,796.86

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,372 shares at $500.5808 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001106578-26-000139 · filed 2026-09-11 · View filing →

SEC FORM 4
$1,126,208.62

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,244 shares at $501.8755 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001106578-26-000139 · filed 2026-09-11 · View filing →

SEC FORM 4
$772,300.03

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,536 shares at $502.7995 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001106578-26-000139 · filed 2026-09-11 · View filing →

SEC FORM 4
$291,173.86

UNITED THERAPEUTICS Corp (UTHR)

Sale of 578 shares at $503.761 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001106578-26-000139 · filed 2026-09-11 · View filing →

SEC FORM 4
$354,532.74

UNITED THERAPEUTICS Corp (UTHR)

Sale of 702 shares at $505.0324 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001106578-26-000139 · filed 2026-09-11 · View filing →

SEC FORM 4
$303,564.06

UNITED THERAPEUTICS Corp (UTHR)

Sale of 600 shares at $505.9401 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001106578-26-000139 · filed 2026-09-11 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$576,122.98

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,144 shares at $503.604 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$486,847.28

UNITED THERAPEUTICS Corp (UTHR)

Sale of 964 shares at $505.0283 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$442,559.51

UNITED THERAPEUTICS Corp (UTHR)

Sale of 875 shares at $505.7823 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$402,429.13

UNITED THERAPEUTICS Corp (UTHR)

Sale of 794 shares at $506.8377 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$256,884.82

UNITED THERAPEUTICS Corp (UTHR)

Sale of 506 shares at $507.6775 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$101,800.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $509.00 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$39,504.46

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $493.8058 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$595,774.79

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,202 shares at $495.6529 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$634,816.59

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,278 shares at $496.7266 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$79,609.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $497.5575 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$199,539.44

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $498.8486 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$259,362.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 519 shares at $499.7341 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$180,802.99

UNITED THERAPEUTICS Corp (UTHR)

Sale of 361 shares at $500.8393 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$511,414.01

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,017 shares at $502.8653 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001106578-26-000138 · filed 2026-09-10 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$947,531.13

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,902 shares at $498.1762 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$507,746.13

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,018 shares at $498.7683 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$586,733.54

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,173 shares at $500.1991 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$611,934.06

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,221 shares at $501.1745 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$586,134.85

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,167 shares at $502.2578 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$352,833.07

UNITED THERAPEUTICS Corp (UTHR)

Sale of 701 shares at $503.3282 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$210,733.32

UNITED THERAPEUTICS Corp (UTHR)

Sale of 418 shares at $504.1467 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$19,276.47

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $481.9118 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$96,780.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $483.90 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$108,028.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 220 shares at $491.0382 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$68,980.28

UNITED THERAPEUTICS Corp (UTHR)

Sale of 140 shares at $492.7163 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$71,133.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 144 shares at $493.9821 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$296,923.44

UNITED THERAPEUTICS Corp (UTHR)

Sale of 600 shares at $494.8724 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$126,912.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 256 shares at $495.7508 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$149,115.06

UNITED THERAPEUTICS Corp (UTHR)

Sale of 300 shares at $497.0502 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001106578-26-000137 · filed 2026-09-09 · View filing →

SEC FORM 4
$1,118,720.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 4, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001106578-26-000136 · filed 2026-09-08 · View filing →

SEC FORM 4
$19,433.82

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $485.8455 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001106578-26-000136 · filed 2026-09-08 · View filing →

SEC FORM 4
$108,573.86

UNITED THERAPEUTICS Corp (UTHR)

Sale of 223 shares at $486.8783 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001106578-26-000136 · filed 2026-09-08 · View filing →

SEC FORM 4
$1,375,398.17

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,818 shares at $488.076 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001106578-26-000136 · filed 2026-09-08 · View filing →

SEC FORM 4
$1,675,248.33

UNITED THERAPEUTICS Corp (UTHR)

Sale of 3,425 shares at $489.1236 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001106578-26-000136 · filed 2026-09-08 · View filing →

SEC FORM 4
$741,873.93

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,514 shares at $490.0092 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001106578-26-000136 · filed 2026-09-08 · View filing →

SEC FORM 4
$569,484.72

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,160 shares at $490.9351 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001106578-26-000136 · filed 2026-09-08 · View filing →

SEC FORM 4
$157,341.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $491.6925 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001106578-26-000136 · filed 2026-09-08 · View filing →

SEC FORM 4
$1,206,592.20

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 8,910 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$697,159.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,429 shares at $487.8655 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$783,847.05

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,604 shares at $488.6827 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$1,524,667.03

UNITED THERAPEUTICS Corp (UTHR)

Sale of 3,114 shares at $489.6169 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$461,070.38

UNITED THERAPEUTICS Corp (UTHR)

Sale of 940 shares at $490.5004 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$20,632.30

UNITED THERAPEUTICS Corp (UTHR)

Sale of 42 shares at $491.2452 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$69,478.40

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 590 shares at $117.76 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$95,813.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $479.066 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$211,431.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 440 shares at $480.5257 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$288,883.56

UNITED THERAPEUTICS Corp (UTHR)

Sale of 600 shares at $481.4726 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$192,938.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $482.345 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$38,695.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $483.69 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$116,438.04

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $485.1585 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$200,043.56

UNITED THERAPEUTICS Corp (UTHR)

Sale of 411 shares at $486.724 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →

SEC FORM 4
$1,212,049.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 8,300 shares at $146.03 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code M

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$82,364.21

UNITED THERAPEUTICS Corp (UTHR)

Sale of 169 shares at $487.3622 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$4,883.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 10 shares at $488.32 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$157,083.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $490.885 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$739,953.65

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,545 shares at $478.9344 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$448,959.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 936 shares at $479.6575 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$1,134,832.67

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,360 shares at $480.8613 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$505,049.02

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,048 shares at $481.917 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$77,226.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $482.6625 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$96,769.88

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $483.8494 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$462,807.15

UNITED THERAPEUTICS Corp (UTHR)

Sale of 954 shares at $485.1228 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$290,907.98

UNITED THERAPEUTICS Corp (UTHR)

Sale of 598 shares at $486.4682 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231589-26-000019 · filed 2026-09-03 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$900,703.94

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,833 shares at $491.3824 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$1,017,487.57

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,067 shares at $492.2533 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$256,668.10

UNITED THERAPEUTICS Corp (UTHR)

Sale of 520 shares at $493.5925 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$257,051.18

UNITED THERAPEUTICS Corp (UTHR)

Sale of 520 shares at $494.3292 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$209,788.54

UNITED THERAPEUTICS Corp (UTHR)

Sale of 423 shares at $495.954 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$386,128.36

UNITED THERAPEUTICS Corp (UTHR)

Sale of 777 shares at $496.9477 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$181,347.06

UNITED THERAPEUTICS Corp (UTHR)

Sale of 364 shares at $498.2062 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$270,442.88

UNITED THERAPEUTICS Corp (UTHR)

Sale of 542 shares at $498.9721 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$27,011.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 54 shares at $500.2185 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$80,170.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $501.0625 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$57,323.64

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $477.697 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$60,241.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $502.01 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$100,829.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $504.148 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$20,208.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $505.20 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$20,250.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $506.27 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$40,668.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $508.36 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$81,608.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $510.05 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$76,615.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $478.8475 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$76,782.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $479.8875 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$38,608.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $482.61 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$58,214.56

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $485.1213 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$77,810.85

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $486.3178 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$117,373.34

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $489.0556 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$274,506.68

UNITED THERAPEUTICS Corp (UTHR)

Sale of 560 shares at $490.1905 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001106578-26-000133 · filed 2026-09-02 · View filing →

SEC FORM 4
$163,431.71

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $510.7241 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001106578-26-000133 · filed 2026-09-02 · View filing →

SEC FORM 4
$422,359.16

UNITED THERAPEUTICS Corp (UTHR)

Sale of 825 shares at $511.9505 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001106578-26-000133 · filed 2026-09-02 · View filing →

SEC FORM 4
$888,721.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,732 shares at $513.1186 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001106578-26-000133 · filed 2026-09-02 · View filing →

SEC FORM 4
$1,775,676.19

UNITED THERAPEUTICS Corp (UTHR)

Sale of 3,454 shares at $514.0927 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001106578-26-000133 · filed 2026-09-02 · View filing →

SEC FORM 4
$834,272.46

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,620 shares at $514.983 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001106578-26-000133 · filed 2026-09-02 · View filing →

SEC FORM 4
$758,048.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,469 shares at $516.0305 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001106578-26-000133 · filed 2026-09-02 · View filing →

SEC FORM 4
$41,329.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $516.62 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001106578-26-000133 · filed 2026-09-02 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001106578-26-000132 · filed 2026-09-01 · View filing →

SEC FORM 4
$304,198.38

UNITED THERAPEUTICS Corp (UTHR)

Sale of 599 shares at $507.8437 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001106578-26-000132 · filed 2026-09-01 · View filing →

SEC FORM 4
$404,082.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 794 shares at $508.9199 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001106578-26-000132 · filed 2026-09-01 · View filing →

SEC FORM 4
$412,967.08

UNITED THERAPEUTICS Corp (UTHR)

Sale of 810 shares at $509.8359 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001106578-26-000132 · filed 2026-09-01 · View filing →

SEC FORM 4
$2,154,598.14

UNITED THERAPEUTICS Corp (UTHR)

Sale of 4,217 shares at $510.9315 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001106578-26-000132 · filed 2026-09-01 · View filing →

SEC FORM 4
$818,800.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,600 shares at $511.7505 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001106578-26-000132 · filed 2026-09-01 · View filing →

SEC FORM 4
$348,154.29

UNITED THERAPEUTICS Corp (UTHR)

Sale of 678 shares at $513.5019 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001106578-26-000132 · filed 2026-09-01 · View filing →

SEC FORM 4
$391,912.91

UNITED THERAPEUTICS Corp (UTHR)

Sale of 762 shares at $514.3214 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001106578-26-000132 · filed 2026-09-01 · View filing →

SEC FORM 4
$20,598.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $514.96 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001106578-26-000132 · filed 2026-09-01 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$270,081.94

UNITED THERAPEUTICS Corp (UTHR)

Sale of 517 shares at $522.4022 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$3,140.55

UNITED THERAPEUTICS Corp (UTHR)

Sale of 6 shares at $523.425 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$104,883.50

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $524.4175 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$246,843.36

UNITED THERAPEUTICS Corp (UTHR)

Sale of 480 shares at $514.257 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$840,197.68

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,630 shares at $515.4587 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$1,231,550.84

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,386 shares at $516.1571 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$768,421.45

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,486 shares at $517.1073 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$697,421.02

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,346 shares at $518.1434 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$213,907.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 412 shares at $519.1925 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$390,743.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 751 shares at $520.2975 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$149,172.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 286 shares at $521.5815 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001106578-26-000131 · filed 2026-08-31 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$248,629.38

UNITED THERAPEUTICS Corp (UTHR)

Sale of 477 shares at $521.2356 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$146,272.81

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $522.4029 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$125,664.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $523.60 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$390,310.36

UNITED THERAPEUTICS Corp (UTHR)

Sale of 744 shares at $524.6107 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$197,632.18

UNITED THERAPEUTICS Corp (UTHR)

Sale of 376 shares at $525.6175 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$147,384.75

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $526.3741 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$653,500.05

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,237 shares at $528.2943 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$692,127.68

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,308 shares at $529.1496 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$400,210.10

UNITED THERAPEUTICS Corp (UTHR)

Sale of 755 shares at $530.0796 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$63,734.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $531.12 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$252,718.10

UNITED THERAPEUTICS Corp (UTHR)

Sale of 494 shares at $511.5751 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$329,006.64

UNITED THERAPEUTICS Corp (UTHR)

Sale of 642 shares at $512.4714 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$361,434.44

UNITED THERAPEUTICS Corp (UTHR)

Sale of 704 shares at $513.4012 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$61,718.41

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $514.3201 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$123,679.18

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $515.3299 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$144,779.68

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $517.0703 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$103,778.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $518.894 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$521,794.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,003 shares at $520.234 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001106578-26-000130 · filed 2026-08-28 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 26, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001106578-26-000129 · filed 2026-08-27 · View filing →

SEC FORM 4
$287,682.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 559 shares at $514.6376 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001106578-26-000129 · filed 2026-08-27 · View filing →

SEC FORM 4
$820,009.51

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,591 shares at $515.4051 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001106578-26-000129 · filed 2026-08-27 · View filing →

SEC FORM 4
$582,832.07

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,128 shares at $516.6951 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001106578-26-000129 · filed 2026-08-27 · View filing →

SEC FORM 4
$1,819,502.93

UNITED THERAPEUTICS Corp (UTHR)

Sale of 3,516 shares at $517.4923 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001106578-26-000129 · filed 2026-08-27 · View filing →

SEC FORM 4
$927,846.14

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,790 shares at $518.3498 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001106578-26-000129 · filed 2026-08-27 · View filing →

SEC FORM 4
$247,210.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 476 shares at $519.3502 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001106578-26-000129 · filed 2026-08-27 · View filing →

SEC FORM 4
$208,246.76

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $520.6169 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001106578-26-000129 · filed 2026-08-27 · View filing →

SEC FORM 4
$20,859.08

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $521.477 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001106578-26-000129 · filed 2026-08-27 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001106578-26-000128 · filed 2026-08-26 · View filing →

SEC FORM 4
$1,047,204.84

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,029 shares at $516.1187 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001106578-26-000128 · filed 2026-08-26 · View filing →

SEC FORM 4
$1,205,518.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,332 shares at $516.9461 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001106578-26-000128 · filed 2026-08-26 · View filing →

SEC FORM 4
$1,038,238.13

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,004 shares at $518.0829 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001106578-26-000128 · filed 2026-08-26 · View filing →

SEC FORM 4
$1,238,375.36

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,387 shares at $518.7999 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001106578-26-000128 · filed 2026-08-26 · View filing →

SEC FORM 4
$347,296.94

UNITED THERAPEUTICS Corp (UTHR)

Sale of 668 shares at $519.9056 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001106578-26-000128 · filed 2026-08-26 · View filing →

SEC FORM 4
$41,639.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $520.495 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001106578-26-000128 · filed 2026-08-26 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 24, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001106578-26-000127 · filed 2026-08-25 · View filing →

SEC FORM 4
$114,108.22

UNITED THERAPEUTICS Corp (UTHR)

Sale of 224 shares at $509.4117 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001106578-26-000127 · filed 2026-08-25 · View filing →

SEC FORM 4
$675,420.74

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,323 shares at $510.5221 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001106578-26-000127 · filed 2026-08-25 · View filing →

SEC FORM 4
$1,563,537.92

UNITED THERAPEUTICS Corp (UTHR)

Sale of 3,056 shares at $511.6289 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001106578-26-000127 · filed 2026-08-25 · View filing →

SEC FORM 4
$1,840,742.67

UNITED THERAPEUTICS Corp (UTHR)

Sale of 3,592 shares at $512.4562 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001106578-26-000127 · filed 2026-08-25 · View filing →

SEC FORM 4
$669,920.58

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,305 shares at $513.3491 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001106578-26-000127 · filed 2026-08-25 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$193,395.18

UNITED THERAPEUTICS Corp (UTHR)

Sale of 371 shares at $521.2808 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$349,411.34

UNITED THERAPEUTICS Corp (UTHR)

Sale of 669 shares at $522.289 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$238,247.46

UNITED THERAPEUTICS Corp (UTHR)

Sale of 455 shares at $523.6208 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$327,719.69

UNITED THERAPEUTICS Corp (UTHR)

Sale of 625 shares at $524.3515 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$123,473.75

UNITED THERAPEUTICS Corp (UTHR)

Sale of 235 shares at $525.4202 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$23,691.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 45 shares at $526.4667 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$105,541.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $527.708 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$609,616.59

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,189 shares at $512.7137 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$139,254.33

UNITED THERAPEUTICS Corp (UTHR)

Sale of 271 shares at $513.8536 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$321,523.68

UNITED THERAPEUTICS Corp (UTHR)

Sale of 624 shares at $515.2623 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$871,776.67

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,689 shares at $516.1496 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$399,694.80

UNITED THERAPEUTICS Corp (UTHR)

Sale of 773 shares at $517.0696 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$558,031.50

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,077 shares at $518.1351 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$434,474.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 837 shares at $519.0852 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$228,813.95

UNITED THERAPEUTICS Corp (UTHR)

Sale of 440 shares at $520.0317 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001106578-26-000126 · filed 2026-08-24 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001106578-26-000125 · filed 2026-08-21 · View filing →

SEC FORM 4
$506,005.54

UNITED THERAPEUTICS Corp (UTHR)

Sale of 976 shares at $518.4483 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001106578-26-000125 · filed 2026-08-21 · View filing →

SEC FORM 4
$781,344.09

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,504 shares at $519.5107 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001106578-26-000125 · filed 2026-08-21 · View filing →

SEC FORM 4
$1,226,712.67

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,357 shares at $520.4551 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001106578-26-000125 · filed 2026-08-21 · View filing →

SEC FORM 4
$1,287,842.93

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,470 shares at $521.3939 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001106578-26-000125 · filed 2026-08-21 · View filing →

SEC FORM 4
$501,476.64

UNITED THERAPEUTICS Corp (UTHR)

Sale of 960 shares at $522.3715 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001106578-26-000125 · filed 2026-08-21 · View filing →

SEC FORM 4
$418,606.56

UNITED THERAPEUTICS Corp (UTHR)

Sale of 800 shares at $523.2582 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001106578-26-000125 · filed 2026-08-21 · View filing →

SEC FORM 4
$126,023.11

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $525.0963 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001106578-26-000125 · filed 2026-08-21 · View filing →

SEC FORM 4
$101,705.19

UNITED THERAPEUTICS Corp (UTHR)

Sale of 193 shares at $526.9699 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001106578-26-000125 · filed 2026-08-21 · View filing →

SEC FORM 4
$392,820.70

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 2,690 shares at $146.03 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code M

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001231589-26-000018 · filed 2026-08-21 · View filing →

SEC FORM 4
$210,554.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 400 shares at $526.385 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001231589-26-000018 · filed 2026-08-21 · View filing →

SEC FORM 4
$63,265.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $527.21 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001231589-26-000018 · filed 2026-08-21 · View filing →

SEC FORM 4
$819,228.30

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 5,610 shares at $146.03 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code M

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001231589-26-000018 · filed 2026-08-21 · View filing →

SEC FORM 4
$1,409,963.50

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,690 shares at $524.15 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001231589-26-000018 · filed 2026-08-21 · View filing →

SEC FORM 4
$261,056.62

UNITED THERAPEUTICS Corp (UTHR)

Sale of 502 shares at $520.0331 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001231589-26-000018 · filed 2026-08-21 · View filing →

SEC FORM 4
$947,772.85

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,819 shares at $521.0406 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001231589-26-000018 · filed 2026-08-21 · View filing →

SEC FORM 4
$410,816.83

UNITED THERAPEUTICS Corp (UTHR)

Sale of 787 shares at $522.0036 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001231589-26-000018 · filed 2026-08-21 · View filing →

SEC FORM 4
$444,366.23

UNITED THERAPEUTICS Corp (UTHR)

Sale of 850 shares at $522.7838 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001231589-26-000018 · filed 2026-08-21 · View filing →

SEC FORM 4
$100,548.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 192 shares at $523.6897 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001231589-26-000018 · filed 2026-08-21 · View filing →

SEC FORM 4
$493,735.38

UNITED THERAPEUTICS Corp (UTHR)

Sale of 940 shares at $525.2504 per share.

Reporting Person MAHON PAUL A · Officer Title EVP & GENERAL COUNSEL · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001231589-26-000018 · filed 2026-08-21 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$106,732.21

UNITED THERAPEUTICS Corp (UTHR)

Sale of 201 shares at $531.006 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$42,529.78

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $531.6223 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$106,526.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $532.63 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$42,817.20

UNITED THERAPEUTICS Corp (UTHR)

Sale of 80 shares at $535.215 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$125,396.78

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $522.4866 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$661,888.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,264 shares at $523.6459 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$231,309.26

UNITED THERAPEUTICS Corp (UTHR)

Sale of 441 shares at $524.5108 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$470,408.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 895 shares at $525.5962 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$1,108,836.54

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,105 shares at $526.7632 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$1,126,375.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,135 shares at $527.5763 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$634,304.64

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,200 shares at $528.5872 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$348,978.92

UNITED THERAPEUTICS Corp (UTHR)

Sale of 659 shares at $529.5583 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001106578-26-000124 · filed 2026-08-20 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001106578-26-000123 · filed 2026-08-19 · View filing →

SEC FORM 4
$844,642.04

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,630 shares at $518.1853 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001106578-26-000123 · filed 2026-08-19 · View filing →

SEC FORM 4
$228,723.59

UNITED THERAPEUTICS Corp (UTHR)

Sale of 441 shares at $518.6476 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001106578-26-000123 · filed 2026-08-19 · View filing →

SEC FORM 4
$121,766.60

UNITED THERAPEUTICS Corp (UTHR)

Sale of 239 shares at $509.4837 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001106578-26-000123 · filed 2026-08-19 · View filing →

SEC FORM 4
$117,919.22

UNITED THERAPEUTICS Corp (UTHR)

Sale of 231 shares at $510.4728 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001106578-26-000123 · filed 2026-08-19 · View filing →

SEC FORM 4
$86,971.00

UNITED THERAPEUTICS Corp (UTHR)

Sale of 170 shares at $511.5941 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001106578-26-000123 · filed 2026-08-19 · View filing →

SEC FORM 4
$225,233.56

UNITED THERAPEUTICS Corp (UTHR)

Sale of 439 shares at $513.0605 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001106578-26-000123 · filed 2026-08-19 · View filing →

SEC FORM 4
$649,918.34

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,264 shares at $514.1759 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001106578-26-000123 · filed 2026-08-19 · View filing →

SEC FORM 4
$1,201,463.74

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,333 shares at $514.9866 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001106578-26-000123 · filed 2026-08-19 · View filing →

SEC FORM 4
$970,164.22

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,880 shares at $516.0448 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001106578-26-000123 · filed 2026-08-19 · View filing →

SEC FORM 4
$451,418.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 873 shares at $517.089 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001106578-26-000123 · filed 2026-08-19 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001106578-26-000122 · filed 2026-08-18 · View filing →

SEC FORM 4
$106,726.14

UNITED THERAPEUTICS Corp (UTHR)

Sale of 213 shares at $501.0617 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001106578-26-000122 · filed 2026-08-18 · View filing →

SEC FORM 4
$214,431.37

UNITED THERAPEUTICS Corp (UTHR)

Sale of 427 shares at $502.1812 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001106578-26-000122 · filed 2026-08-18 · View filing →

SEC FORM 4
$60,504.79

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $504.2066 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001106578-26-000122 · filed 2026-08-18 · View filing →

SEC FORM 4
$625,637.54

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,238 shares at $505.3615 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001106578-26-000122 · filed 2026-08-18 · View filing →

SEC FORM 4
$1,276,510.37

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,521 shares at $506.3508 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001106578-26-000122 · filed 2026-08-18 · View filing →

SEC FORM 4
$1,673,503.81

UNITED THERAPEUTICS Corp (UTHR)

Sale of 3,298 shares at $507.4299 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001106578-26-000122 · filed 2026-08-18 · View filing →

SEC FORM 4
$855,254.32

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,683 shares at $508.1725 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001106578-26-000122 · filed 2026-08-18 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001106578-26-000121 · filed 2026-08-17 · View filing →

SEC FORM 4
$158,407.42

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $495.0232 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001106578-26-000121 · filed 2026-08-17 · View filing →

SEC FORM 4
$205,329.43

UNITED THERAPEUTICS Corp (UTHR)

Sale of 414 shares at $495.9648 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001106578-26-000121 · filed 2026-08-17 · View filing →

SEC FORM 4
$267,006.71

UNITED THERAPEUTICS Corp (UTHR)

Sale of 537 shares at $497.2192 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001106578-26-000121 · filed 2026-08-17 · View filing →

SEC FORM 4
$1,061,579.65

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,130 shares at $498.3942 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001106578-26-000121 · filed 2026-08-17 · View filing →

SEC FORM 4
$1,812,445.57

UNITED THERAPEUTICS Corp (UTHR)

Sale of 3,630 shares at $499.2963 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001106578-26-000121 · filed 2026-08-17 · View filing →

SEC FORM 4
$1,074,098.59

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,148 shares at $500.0459 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001106578-26-000121 · filed 2026-08-17 · View filing →

SEC FORM 4
$160,796.93

UNITED THERAPEUTICS Corp (UTHR)

Sale of 321 shares at $500.925 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001106578-26-000121 · filed 2026-08-17 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$325,605.82

UNITED THERAPEUTICS Corp (UTHR)

Sale of 640 shares at $508.7591 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$101,984.84

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $509.9242 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$81,779.36

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $511.121 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$122,966.28

UNITED THERAPEUTICS Corp (UTHR)

Sale of 240 shares at $512.3595 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$626,597.61

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,253 shares at $500.0779 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$665,237.70

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,328 shares at $500.932 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$762,352.23

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,519 shares at $501.8777 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$221,288.19

UNITED THERAPEUTICS Corp (UTHR)

Sale of 440 shares at $502.9277 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$80,612.14

UNITED THERAPEUTICS Corp (UTHR)

Sale of 160 shares at $503.8259 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$485,477.21

UNITED THERAPEUTICS Corp (UTHR)

Sale of 961 shares at $505.1792 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$849,844.65

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,679 shares at $506.1612 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$466,570.36

UNITED THERAPEUTICS Corp (UTHR)

Sale of 920 shares at $507.1417 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001106578-26-000120 · filed 2026-08-14 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$485,190.96

UNITED THERAPEUTICS Corp (UTHR)

Sale of 940 shares at $516.1606 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$646,001.04

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,249 shares at $517.2146 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$165,810.11

UNITED THERAPEUTICS Corp (UTHR)

Sale of 320 shares at $518.1566 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$602,607.01

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,160 shares at $519.4888 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$353,336.59

UNITED THERAPEUTICS Corp (UTHR)

Sale of 679 shares at $520.3779 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$21,359.35

UNITED THERAPEUTICS Corp (UTHR)

Sale of 41 shares at $520.9598 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$20,283.04

UNITED THERAPEUTICS Corp (UTHR)

Sale of 40 shares at $507.076 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$223,898.31

UNITED THERAPEUTICS Corp (UTHR)

Sale of 440 shares at $508.8598 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$142,691.19

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $509.6114 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$588,807.71

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,152 shares at $511.1178 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$277,366.93

UNITED THERAPEUTICS Corp (UTHR)

Sale of 542 shares at $511.7471 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$618,698.26

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,206 shares at $513.0168 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$286,914.62

UNITED THERAPEUTICS Corp (UTHR)

Sale of 558 shares at $514.1839 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$459,783.02

UNITED THERAPEUTICS Corp (UTHR)

Sale of 893 shares at $514.8746 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001106578-26-000119 · filed 2026-08-13 · View filing →

SEC FORM 4
$1,286,490.00

UNITED THERAPEUTICS Corp (UTHR)

Acquisition (code M) of 9,500 shares at $135.42 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code M

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$115,591.04

UNITED THERAPEUTICS Corp (UTHR)

Sale of 221 shares at $523.0364 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$198,646.90

UNITED THERAPEUTICS Corp (UTHR)

Sale of 379 shares at $524.1343 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$457,442.23

UNITED THERAPEUTICS Corp (UTHR)

Sale of 871 shares at $525.192 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,433,481.34

UNITED THERAPEUTICS Corp (UTHR)

Sale of 2,725 shares at $526.0482 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$492,895.16

UNITED THERAPEUTICS Corp (UTHR)

Sale of 935 shares at $527.1606 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$389,185.82

UNITED THERAPEUTICS Corp (UTHR)

Sale of 737 shares at $528.0676 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$75,654.41

UNITED THERAPEUTICS Corp (UTHR)

Sale of 143 shares at $529.0518 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$148,682.97

UNITED THERAPEUTICS Corp (UTHR)

Sale of 280 shares at $531.0106 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$243,851.61

UNITED THERAPEUTICS Corp (UTHR)

Sale of 475 shares at $513.3718 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$624,632.99

UNITED THERAPEUTICS Corp (UTHR)

Sale of 1,214 shares at $514.5247 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$185,585.51

UNITED THERAPEUTICS Corp (UTHR)

Sale of 360 shares at $515.5153 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$268,793.93

UNITED THERAPEUTICS Corp (UTHR)

Sale of 520 shares at $516.9114 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$62,108.40

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $517.57 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$62,274.34

UNITED THERAPEUTICS Corp (UTHR)

Sale of 120 shares at $518.9528 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$104,118.68

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $520.5934 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →

SEC FORM 4
$104,346.66

UNITED THERAPEUTICS Corp (UTHR)

Sale of 200 shares at $521.7333 per share.

Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001106578-26-000118 · filed 2026-08-12 · View filing →